Ocular Changes in the Mucopolysaccharidoses After Bone Marrow Transplantation. A Preliminary Report
Overview
Affiliations
Metabolic correction and physiologic response were evaluated after bone marrow transplantation in mucopolysaccharidosis. Eleven patients were prospectively evaluated to determine the effect of bone marrow transplantation on the progressive ocular manifestations of these disorders. Follow-up of 0.6 to 2.8 years after successful donor stem cell engraftment showed that some patients had slow clearing of the corneal clouding, reduction of intracytoplasmic inclusions in the conjunctiva, resolution of optic nerve edema, and stabilized or improved retinal function as determined by electroretinography. These preliminary results suggest that early bone marrow transplantation may alter some of the progressive ophthalmic characteristics of the mucopolysaccharidoses. Long-term follow-up is necessary to determine if these early alterations in the ocular features are predictive of a prolonged functional improvement in the visual status.
Huryn L, Kozycki C, Serpen J, Zein W, Ullah E, Iannaccone A Ophthalmology. 2022; 130(4):423-432.
PMID: 36332842 PMC: 10038920. DOI: 10.1016/j.ophtha.2022.10.026.
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.
Hampe C, Wesley J, Lund T, Orchard P, Polgreen L, Eisengart J Biomolecules. 2021; 11(2).
PMID: 33572941 PMC: 7911293. DOI: 10.3390/biom11020189.
Song L, Bower J, Llanga T, Salmon J, Hirsch M, Gilger B Mol Ther Methods Clin Dev. 2020; 18:24-32.
PMID: 32542182 PMC: 7284066. DOI: 10.1016/j.omtm.2020.05.014.
Miyadera K, Conatser L, Llanga T, Carlin K, ODonnell P, Bagel J Mol Ther. 2020; 28(6):1455-1463.
PMID: 32330426 PMC: 7264440. DOI: 10.1016/j.ymthe.2020.04.004.
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.
Akyol M, Alden T, Amartino H, Ashworth J, Belani K, Berger K Orphanet J Rare Dis. 2019; 14(1):118.
PMID: 31142378 PMC: 6541999. DOI: 10.1186/s13023-019-1080-y.